Showing 61,861 - 61,880 results of 226,405 for search '(( a ((((mean decrease) OR (a decrease))) OR (linear decrease)) ) OR ( a large decrease ))', query time: 1.84s Refine Results
  1. 61861

    Datasheet1_Efficacy and safety of levetiracetam vs. oxcarbazepine in the treatment of children with epilepsy: a systematic review and meta-analysis.csv by Yuanyuan Liu (136992)

    Published 2024
    “…In addition, included cohort studies quality was determined using Newcastle-Ottawa Scale (NOS). A random-effects model was utilized to summarize the results.…”
  2. 61862

    Datasheet2_Efficacy and safety of levetiracetam vs. oxcarbazepine in the treatment of children with epilepsy: a systematic review and meta-analysis.pdf by Yuanyuan Liu (136992)

    Published 2024
    “…In addition, included cohort studies quality was determined using Newcastle-Ottawa Scale (NOS). A random-effects model was utilized to summarize the results.…”
  3. 61863

    Data_Sheet_1_Pain Management in Acute Pancreatitis: A Systematic Review and Meta-Analysis of Randomised Controlled Trials.docx by Wenhao Cai (3709966)

    Published 2021
    “…Pooled odds ratios (ORs) or weighted mean differences (WMDs) with 95% confidence intervals (CI) were analysed using a random-effects model.…”
  4. 61864

    Association between mitochondrial DNA copy number and cardiovascular disease: Current evidence based on a systematic review and meta-analysis by Peng Yue (62395)

    Published 2018
    “…The normalized mtDNA copy number level is lower in cardiovascular disease (CVD) than the control groups with a pooled standard mean difference (SMD) of -0.36(95%CI,-0.65 to -0.08); The pooled odds ratio (OR) for CVD proportion associated with a 1-SD (standard deviation) decrease in mtDNA copy number level is 1.23 (95% CI,1.06–1.42); The OR for CVD patients with mtDNA copy number lower than median level is 1.88(95% CI,1.65–2.13); The OR for CVD patients with mtDNA copy number located in the lowest quartile part is 2.15(95% CI, 1.46–3.18); the OR between mtDNA copy number and the risk of sudden cardiac death (SCD) is 1.83(95% CI, 1.22–2.74).…”
  5. 61865
  6. 61866
  7. 61867
  8. 61868
  9. 61869

    Data_Sheet_1_Effect of dietary inflammatory potential on the aging acceleration for cardiometabolic disease: A population-based study.docx by Yuanlong Hu (5618291)

    Published 2022
    “…The each one-unit increase in CVH score was associated with a 1.58-years decrease in KDMAccel (β = −1.58, 95% CI = −1.68 to −1.49, P < 0.001) and a 0.36-years in PhenoAgeAccel (β = −0.36, 95% CI = −0.41 to −0.31, P < 0.001).…”
  10. 61870

    Invention of MK-8262, a Cholesteryl Ester Transfer Protein (CETP) Inhibitor Backup to Anacetrapib with Best-in-Class Properties by Petr Vachal (1445962)

    Published 2021
    “…This relationship is consistent with a clinical outcomes trial of a CETP inhibitor (anacetrapib) combined with standard of care (statin), which led to a 9% additional risk reduction compared to standard of care alone. …”
  11. 61871

    Effects of HTK on H<sub>2</sub>O<sub>2</sub> scavenge in a neuron-free system. by Jiun Hsu (7365779)

    Published 2019
    “…<p>(A) The representative recordings show luminol-mediated CL counts were dose-dependently increased in response to different concentrations of H<sub>2</sub>O<sub>2</sub> after 50 s of background (the first arrow). …”
  12. 61872
  13. 61873
  14. 61874

    Representation of Sound Objects within Early-Stage Auditory Areas: A Repetition Effect Study Using 7T fMRI by Sandra Da Costa (734188)

    Published 2015
    “…Their semantic representations were shown to yield repetition suppression effects, i. e. a decrease in activity during exposure to a sound that is perceived as belonging to the same source as a preceding sound. …”
  15. 61875

    DataSheet1_Association of PM2.5 With blood lipids and dyslipidaemia in a rural population of north-western china.docx by Kairong Wang (1555183)

    Published 2022
    “…Every 1-μg/m<sup>3</sup> increment in PM<sub>2.5</sub> was related with a 4% (95% CI:3–5%) and 18% (95% CI:16–20%) higher risk of dyslipidaemia and hypoalphalipoproteinemia, respectively, and a decrease of 11% (95% CI:10–13%) in hyperbetalipoproteinemia. …”
  16. 61876

    Soluble factors from gingival fibroblasts (GFs) inhibit the differentiation of CD1a<sup>+</sup> dendritic cells. by Sylvie Séguier (441106)

    Published 2013
    “…Percentages of CD1a<sup>+</sup> DC-SIGN<sup>+</sup> dendritic cells decreased with increasing GF/monocyte ratio. …”
  17. 61877

    Examples of APP immunolabeling in the hippocampus of the NC (A), 24H-B (B) and 24H-B/T (C) groups. by Xiaoping Du (284656)

    Published 2013
    “…Error bars represent standard error of the means. Scale bar = 10 µm in C for A-C. *** indicate <i>p</i> < 0.001.…”
  18. 61878

    Cdk1-Mediated Phosphorylation of Human ATF7 at Thr-51 and Thr-53 Promotes Cell-Cycle Progression into M Phase by Hitomi Hasegawa (697973)

    Published 2014
    “…The inducible expression of a mitotically nonphosphorylatable version of ATF7 inhibits G2/M progression despite the presence of endogenous ATF7. …”
  19. 61879
  20. 61880

    Supplementary Material for: Early Environmental Enrichment Enhances Abnormal Brain Connectivity in a Rabbit Model of Intrauterine Growth Restriction by Illa M. (4505281)

    Published 2017
    “…<b><i>Materials and Methods:</i></b> IUGR was surgically induced in one horn, whereas the contralateral one produced the controls. Postnatally, a subgroup of IUGR animals was housed in an enriched environment. …”